All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAART-LX135 | Anti-Nuclear (71F12) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | 71F12 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX136 | Anti-Nuclear (121G9) h(CD28-CD3ζ) CAART, pCDCAAR1 | Human | 121G9 | Human | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX137 | Anti-Nuclear (J3.4) h(CD28-CD3ζ) CAART, pCDCAAR1 | Mouse | J3.4 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX138 | Anti-Nuclear (J9.11) h(CD28-CD3ζ) CAART, pCDCAAR1 | Mouse | J9.11 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX139 | Anti-Nuclear (71F12) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | 71F12 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX140 | Anti-Nuclear (121G9) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Human | 121G9 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX141 | Anti-Nuclear (J3.4) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Mouse | J3.4 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell | ||
CAART-LX142 | Anti-Nuclear (J9.11) h(4-1BB-CD3ζ) CAART, pCDCAAR1 | Mouse | J9.11 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | B cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION